Thomas C. Boone

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Thomas C.
Boone worked as a Senior Vice President of Protein Sciences at Oxford BioTherapeutics Ltd., Vice President of Protein Sciences at Amgen, Inc., and Vice President of Preclinical Research & Development at Zymeworks BC, Inc. He obtained undergraduate degrees from the University of California, Los Angeles and the University of California, Davis.

Precedenti posizioni note di Thomas C. Boone

Società	Posizione	Fine
AMGEN INC.	Corporate Officer/Principal	-
Zymeworks BC, Inc. Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.	Direttore Tecnico/Scientifico/R&S	-
Oxford BioTherapeutics Ltd. Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Thomas C. Boone

Formazione di Thomas C. Boone

University of California, Davis	Undergraduate Degree
University of California, Los Angeles	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private